{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:40:49Z","timestamp":1792269649945,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005845","name":"Hyogo College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005845","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K08603"],"award-info":[{"award-number":["15K08603"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.biopha.2018.01.160","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T21:45:35Z","timestamp":1518039935000},"page":"116-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Psychotomimetic-like behavioral effects of memantine in the mouse"],"prefix":"10.1016","volume":"100","author":[{"given":"Nobue","family":"Kitanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Kitanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Scott","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiya","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiko","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.01.160_bib0005","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system\u2014too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2018.01.160_bib0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(01)01872-9","article-title":"The N-methyl-d-aspartate receptor channel blockers memantine, MRZ 2\/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner","volume":"306","author":"Rammes","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2018.01.160_bib0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0006-8993(88)91630-7","article-title":"Memantine (1-amino-3,5-dimethyladamantane) blocks the serotonin-induced depolarization response in a neuronal cell line","volume":"443","author":"Reiser","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2018.01.160_bib0020","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.104.077172","article-title":"Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-d-aspartate receptors in rat hippocampal neurons","volume":"312","author":"Aracava","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2018.01.160_bib0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/syn.20472","article-title":"Memantine agonist action at dopamine D2High receptors","volume":"62","author":"Seeman","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.biopha.2018.01.160_bib0030","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1474-4422(09)70146-2","article-title":"Memantine in patients with Parkinson\u2019s disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial","volume":"8","author":"Aarsland","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2018.01.160_bib0035","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0149-7634(96)00037-1","article-title":"Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents\u2014preclinical studies","volume":"21","author":"Danysz","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.biopha.2018.01.160_bib0040","first-page":"273","article-title":"Effect of memantine (NMDA antagonist) on Parkinson\u2019s disease: a double-blind crossover randomized study","volume":"22","author":"Merello","year":"1999","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.biopha.2018.01.160_bib0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/gps.4109","article-title":"Memantine improves attention and episodic memory in Parkinson\u2019s disease dementia and dementia with Lewy bodies","volume":"30","author":"Wesnes","year":"2015","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.biopha.2018.01.160_bib0050","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2165\/11201020-000000000-00000","article-title":"Memantine: a review of its use in moderate to severe Alzheimer\u2019s disease","volume":"23","author":"McKeage","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopha.2018.01.160_bib0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2007-979603","article-title":"Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer\u2019s dementia","volume":"28","author":"Muller","year":"1995","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.biopha.2018.01.160_bib0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/1381612043386392","article-title":"NMDA-antagonism (memantine): an alternative pharmacological therapeutic principle in Alzheimer\u2019s and vascular dementia","volume":"10","author":"Koch","year":"2004","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2018.01.160_bib0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF03033787","article-title":"Neuroprotective and symptomatological action of memantine relevant for Alzheimer\u2019s disease\u2014a unified glutamatergic hypothesis on the mechanism of action","volume":"2","author":"Danysz","year":"2000","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.biopha.2018.01.160_bib0070","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s007020050201","article-title":"Dopamine release in the prefrontal cortex in response to memantine following sub-chronic NMDA receptor blockade with memantine: a microdialysis study in rats","volume":"106","author":"Hesselink","year":"1999","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.biopha.2018.01.160_bib0075","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist--a review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2018.01.160_bib0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00008877-200505000-00004","article-title":"A comparison of the predictive therapeutic and undesired side-effects of the NMDA receptor antagonist, memantine, in mice","volume":"16","author":"Kos","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.biopha.2018.01.160_bib0085","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.neubiorev.2005.08.003","article-title":"Rituals, stereotypy and compulsive behavior in animals and humans","volume":"30","author":"Eilam","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.biopha.2018.01.160_bib0090","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.2527\/jas1986.6261776x","article-title":"Behavioral, physiological and functional aspects of stereotyped behavior: a review and a re-interpretation","volume":"62","author":"Dantzer","year":"1986","journal-title":"J. Anim. Sci."},{"key":"10.1016\/j.biopha.2018.01.160_bib0095","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/1570159X12666140619204251","article-title":"The role of ketamine in treatment-resistant depression: a systematic review","volume":"12","author":"Serafini","year":"2014","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2018.01.160_bib0100","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1503\/jpn.160175","article-title":"Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism","volume":"42","author":"Aleksandrova","year":"2017","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.biopha.2018.01.160_bib0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fphar.2013.00161","article-title":"Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants","volume":"4","author":"Browne","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2018.01.160_bib0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00008877-199902000-00008","article-title":"Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration","volume":"10","author":"Hesselink","year":"1999","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.biopha.2018.01.160_bib0115","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1254\/jphs.FPJ04040X","article-title":"Effects of dopamine- and serotonin-related compounds on methamphetamine-induced self-injurious behavior in mice","volume":"96","author":"Mori","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2018.01.160_bib0120","first-page":"CD010696","article-title":"Betahistine for symptoms of vertigo","author":"Murdin","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biopha.2018.01.160_bib0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(85)90115-3","article-title":"Actions of betahistine at histamine receptors in the brain","volume":"111","author":"Arrang","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.01.160_bib0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(02)01795-8","article-title":"Betahistine dihydrochloride interaction with the histaminergic system in the cat: neurochemical and molecular mechanisms","volume":"446","author":"Tighilet","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.01.160_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/DTI.S38342","article-title":"Brain histamine N-methyltransferase as a possible target of treatment for methamphetamine overdose","volume":"10","author":"Kitanaka","year":"2016","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.biopha.2018.01.160_bib0140","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.neuroscience.2007.05.006","article-title":"Blockade of brain histamine metabolism alters methamphetamine-induced expression pattern of stereotypy in mice via histamine H1 receptors","volume":"147","author":"Kitanaka","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2018.01.160_bib0145","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1124\/jpet.110.168633","article-title":"Effects of betahistine at histamine H3 receptors: mixed inverse agonism\/agonism in vitro and partial inverse agonism in vivo","volume":"334","author":"Gbahou","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2018.01.160_bib0150","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-010-2052-z","article-title":"Memantine-induced brain activation as a model for the rapid screening of potential novel antipsychotic compounds: exemplified by activity of an mGlu2\/3 receptor agonist","volume":"214","author":"Dedeurwaerdere","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopha.2018.01.160_bib0155","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s11064-006-9180-1","article-title":"Lobeline attenuates methamphetamine-induced stereotypy in adolescent mice","volume":"31","author":"Tatsuta","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2018.01.160_bib0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pbb.2007.03.019","article-title":"Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice","volume":"87","author":"Tatsuta","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2018.01.160_bib0165","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00213-008-1425-z","article-title":"Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice","volume":"203","author":"Kitanaka","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopha.2018.01.160_bib0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2011.12.043","article-title":"Pretreatment with nomifensine or nomifensine analogue 4-phenyl-1,2,3,4-tetrahydroisoquinoline augments methamphetamine-induced stereotypical behavior in mice","volume":"1439","author":"Kitanaka","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2018.01.160_bib0175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuroscience.2004.09.026","article-title":"Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytryptamine turnover in the striatum","volume":"130","author":"Kitanaka","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2018.01.160_bib0180","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0091-3057(82)90478-6","article-title":"Dopaminergic properties of nomifensine","volume":"17","author":"Gianutsos","year":"1982","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2018.01.160_bib0185","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eplepsyres.2012.03.016","article-title":"Metoprine induced behavioral modifications and brain regional histamine increase in WAG\/Rij and Wistar rats","volume":"101","author":"Samotaeva","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.biopha.2018.01.160_bib0190","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02245171","article-title":"Modulation of MK-801 response by dopaminergic agents in mice","volume":"107","author":"Verma","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopha.2018.01.160_bib0195","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-2999(76)90352-6","article-title":"Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats","volume":"40","author":"Kelly","year":"1976","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.01.160_bib0200","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0006-8993(75)90233-4","article-title":"Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum","volume":"94","author":"Kelly","year":"1975","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2018.01.160_bib0205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-8993(77)90645-X","article-title":"Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei","volume":"123","author":"Costall","year":"1977","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2018.01.160_bib0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0306-4522(94)90062-0","article-title":"Oral stereotypy induced by amphetamine microinjection into striatum: an anatomical mapping study","volume":"61","author":"Dickson","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2018.01.160_bib0215","first-page":"107","article-title":"In vivo studies on the effects of memantine on dopamine metabolism in the striatum and n. accumbens of the rat","volume":"46","author":"Clement","year":"1995","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.biopha.2018.01.160_bib0220","doi-asserted-by":"crossref","first-page":"15523","DOI":"10.1523\/JNEUROSCI.2970-15.2015","article-title":"Glutamate receptors within the mesolimbic dopamine system mediate alcohol relapse behavior","volume":"35","author":"Eisenhardt","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2018.01.160_bib0225","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1517\/14656566.2014.902446","article-title":"Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer\u2019s disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan","volume":"15","author":"Nakamura","year":"2014","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.biopha.2018.01.160_bib0230","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1532-5415.2011.03450.x","article-title":"Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials","volume":"59","author":"Kim","year":"2011","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.biopha.2018.01.160_bib0235","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1474-4422(07)70195-3","article-title":"Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials","volume":"6","author":"Kavirajan","year":"2007","journal-title":"Lancet Neurol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217355142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217355142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T18:04:11Z","timestamp":1761242651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217355142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":47,"alternative-id":["S0753332217355142"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.160","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychotomimetic-like behavioral effects of memantine in the mouse","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.01.160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}